Average Co-Inventor Count = 6.31
ph-index = 10
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Frosst Canada, Inc. (12 from 212 patents)
2. Merck Frosst Canada & Co. (9 from 76 patents)
3. Merck Sharp + Dohme Corp. (2 from 2,405 patents)
4. Merck Canada Inc. (2 from 40 patents)
24 patents:
1. 8518964 - Tricyclic compounds useful as inhibitors of kinases
2. 8343968 - Case of renin inhibitors
3. 8334308 - Renin inhibitors
4. 7618979 - Pyridopyrrolizine and pyridoindolizine derivatives
5. 7429666 - Pyridine analogs as C5a antagonists
6. 7163932 - Aryldifluoromethylphosphonic acids for treatment of diabetes
7. 6583126 - Phosphonic acid derivatives as inhibitors of protein tyrosine phosphatase 1B (PTP-1B)
8. 6498151 - Aryldifluoromethylphosphonic acids with sulfur-containing substituents as PTP-1B inhibitors
9. 6486141 - Phosphonic acid biaryl derivatives as inhibitors of protein tyrosine phosphatase 1B (PTP-1B)
10. 6486142 - Phosphonic acid derivatives as inhibitors of protein tyrosine phosphatase 1B (PTP-1B)
11. 6365592 - Phosphonic and carboxylic acid derivatives as inhibitors of protein tyrosine phosphatase-1B (PTP-1B)
12. 6348572 - Ligands for phosphatase binding assay
13. 6174874 - Phosphonic acids derivatives as inhibitors of protein tyrosine phosphate 1B (PTP-1B)
14. 6169188 - (Methylsulfonyl)phenyl-2-(5H)-furanones as COX-2 inhibitors
15. 6071954 - (methylsulfonyl)phenyl-2-(5H)-furanones with oxygen link as COX-2